|
AUPH Aurinia Pharmaceuticals Inc 1600620 |
| Balance Sheet |
|
Current Assets
|
440,459,000 |
|
Assets
|
549,361,000 |
|
Current Liabilities
|
78,609,000 |
|
Liabilities
|
161,359,000 |
|
Equity
|
388,002,000 |
|
Shares Out
|
142,991,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
14,274,000 |
|
Investing Cash Flow
|
39,000 |
| Market Analysis |
Market Cap
|
1,030,965,115 |
|
Price
|
8.01 |
|
BVPS
|
2.71 |
|
PB
|
2.95 |
|
EPS
|
-0.35 |
|
PS
|
3.80 |
|
FCF
|
14,313,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AUPH documents filed with the SEC.
AUPH Filings
Clear
